181 related articles for article (PubMed ID: 17534677)
1. Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia.
Chokshi R; Restrepo MI; Weeratunge N; Frei CR; Anzueto A; Mortensen EM
Eur J Clin Microbiol Infect Dis; 2007 Jul; 26(7):447-51. PubMed ID: 17534677
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
[TBL] [Abstract][Full Text] [Related]
3. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia.
Viasus D; Simonetti AF; Garcia-Vidal C; Niubó J; Dorca J; Carratalà J
J Antimicrob Chemother; 2017 Feb; 72(2):547-553. PubMed ID: 27798219
[TBL] [Abstract][Full Text] [Related]
4. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study.
Bordón J; Peyrani P; Brock GN; Blasi F; Rello J; File T; Ramirez J;
Chest; 2008 Mar; 133(3):618-24. PubMed ID: 18198264
[TBL] [Abstract][Full Text] [Related]
5. Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae.
Plouffe JF; Martin DR
Infect Dis Clin North Am; 2004 Dec; 18(4):963-74; x-xi. PubMed ID: 15555834
[TBL] [Abstract][Full Text] [Related]
6. Treatment and outcomes for patients with bacteremic pneumococcal pneumonia.
Berjohn CM; Fishman NO; Joffe MM; Edelstein PH; Metlay JP
Medicine (Baltimore); 2008 May; 87(3):160-166. PubMed ID: 18520325
[TBL] [Abstract][Full Text] [Related]
7. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality.
Lujan M; Gallego M; Fontanals D; Mariscal D; Rello J
Crit Care Med; 2004 Mar; 32(3):625-31. PubMed ID: 15090938
[TBL] [Abstract][Full Text] [Related]
8. The Roles of the Charlson Comorbidity Index and Time to First Antibiotic Dose as Predictors of Outcome in Pneumococcal Community-Acquired Pneumonia.
Franzen D; Lim M; Bratton DJ; Kuster SP; Kohler M
Lung; 2016 Oct; 194(5):769-75. PubMed ID: 27405854
[TBL] [Abstract][Full Text] [Related]
9. Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia.
Metlay JP; Hofmann J; Cetron MS; Fine MJ; Farley MM; Whitney C; Breiman RF
Clin Infect Dis; 2000 Mar; 30(3):520-8. PubMed ID: 10722438
[TBL] [Abstract][Full Text] [Related]
10. Optimal antibiotic treatment in severe pneumococcal pneumonia--time for real answers.
Waterer GW
Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):691-2. PubMed ID: 16244854
[No Abstract] [Full Text] [Related]
11. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study.
Mongardon N; Max A; Bouglé A; Pène F; Lemiale V; Charpentier J; Cariou A; Chiche JD; Bedos JP; Mira JP
Crit Care; 2012 Aug; 16(4):R155. PubMed ID: 22894879
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults.
Weiss K; Low DE; Cortes L; Beaupre A; Gauthier R; Gregoire P; Legare M; Nepveu F; Thibert D; Tremblay C; Tremblay J
Can Respir J; 2004; 11(8):589-93. PubMed ID: 15611810
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for Streptococcus pneumoniae Pneumonia.
Cilloniz C; Albert RK; Liapikou A; Gabarrus A; Rangel E; Bello S; Marco F; Mensa J; Torres A
Am J Respir Crit Care Med; 2015 Jun; 191(11):1265-72. PubMed ID: 25807239
[TBL] [Abstract][Full Text] [Related]
14. Optimal therapy for severe pneumococcal community-acquired pneumonia.
Luján M; Gallego M; Rello J
Intensive Care Med; 2006 Jul; 32(7):971-80. PubMed ID: 16791660
[TBL] [Abstract][Full Text] [Related]
15. Severe pneumococcal pneumonia: new strategies for management.
Chiou CC; Yu VL
Curr Opin Crit Care; 2006 Oct; 12(5):470-6. PubMed ID: 16943728
[TBL] [Abstract][Full Text] [Related]
16. What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?
File TM; Mandell LA
Clin Infect Dis; 2003 Feb; 36(4):396-8. PubMed ID: 12567295
[No Abstract] [Full Text] [Related]
17. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia.
Naucler P; Darenberg J; Morfeldt E; Ortqvist A; Henriques Normark B
Thorax; 2013 Jun; 68(6):571-9. PubMed ID: 23442364
[TBL] [Abstract][Full Text] [Related]
18. [Clinical predictors of bacteremia in immunocompetent adult patients hospitalized for community-acquired pneumonia].
Saldías P F; Reyes B T; Sáez B J; Rain M C; Illanes C P; Briceño V C; Díaz P O
Rev Med Chil; 2015 May; 143(5):553-61. PubMed ID: 26203565
[TBL] [Abstract][Full Text] [Related]
19. Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia.
Waterer GW; Somes GW; Wunderink RG
Arch Intern Med; 2001 Aug 13-27; 161(15):1837-42. PubMed ID: 11493124
[TBL] [Abstract][Full Text] [Related]
20. Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia.
Arnold FW; Lopardo G; Wiemken TL; Kelley R; Peyrani P; Mattingly WA; Feldman C; Gnoni M; Maurici R; Ramirez JA;
Respir Med; 2018 Jul; 140():115-121. PubMed ID: 29957272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
